PL3883594T3 - Skład i metody regulacji proliferacji chondrocytów oraz zwiększania produkcji macierzy chrzęstnej - Google Patents

Skład i metody regulacji proliferacji chondrocytów oraz zwiększania produkcji macierzy chrzęstnej

Info

Publication number
PL3883594T3
PL3883594T3 PL19806339.8T PL19806339T PL3883594T3 PL 3883594 T3 PL3883594 T3 PL 3883594T3 PL 19806339 T PL19806339 T PL 19806339T PL 3883594 T3 PL3883594 T3 PL 3883594T3
Authority
PL
Poland
Prior art keywords
increasing
composition
methods
cartilage matrix
matrix production
Prior art date
Application number
PL19806339.8T
Other languages
English (en)
Inventor
Francis Berenbaum
Revital RATTENBACH
Céline MARTIN
Coralie Meurot
Original Assignee
4Moving Biotech
Sorbonne Universite
Assistance Publique - Hôpitaux De Paris
Institut National De La Sante Et De La Recherche Medicale (Inserm)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 4Moving Biotech, Sorbonne Universite, Assistance Publique - Hôpitaux De Paris, Institut National De La Sante Et De La Recherche Medicale (Inserm) filed Critical 4Moving Biotech
Publication of PL3883594T3 publication Critical patent/PL3883594T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL19806339.8T 2018-11-19 2019-11-18 Skład i metody regulacji proliferacji chondrocytów oraz zwiększania produkcji macierzy chrzęstnej PL3883594T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2018/059100 WO2020104833A1 (en) 2018-11-19 2018-11-19 Composition and methods for regulating chondrocyte proliferation and increasing of cartilage matrix production
PCT/IB2019/059889 WO2020104917A1 (en) 2018-11-19 2019-11-18 Composition and methods for regulating chondrocyte proliferation and increasing of cartilage matrix production

Publications (1)

Publication Number Publication Date
PL3883594T3 true PL3883594T3 (pl) 2025-11-12

Family

ID=64650445

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19806339.8T PL3883594T3 (pl) 2018-11-19 2019-11-18 Skład i metody regulacji proliferacji chondrocytów oraz zwiększania produkcji macierzy chrzęstnej

Country Status (12)

Country Link
US (3) US20210401944A1 (pl)
EP (2) EP3883594B1 (pl)
JP (2) JP7661222B2 (pl)
KR (1) KR20210093252A (pl)
CN (1) CN113038966A (pl)
AU (2) AU2019383576B2 (pl)
BR (1) BR112021009232A2 (pl)
CA (1) CA3119940A1 (pl)
ES (1) ES3042788T3 (pl)
HR (1) HRP20251230T1 (pl)
PL (1) PL3883594T3 (pl)
WO (2) WO2020104833A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022269001A1 (en) 2021-06-23 2022-12-29 4Moving Biotech Pharmaceutical compositions comprising glp-1r agonists
EP4108252A1 (en) 2021-06-23 2022-12-28 4Moving Biotech Pharmaceutical compositions comprising glp-1r agonists
CN114934012B (zh) * 2022-05-16 2023-11-10 同济大学 一种纳米层状双氢氧化物在软骨再生中的应用及其制备
CN117701569B (zh) * 2023-12-15 2024-10-18 陕西彦奎生物科技有限公司 一种软骨细胞对半月板损伤与骨关节修复的组合物及其制备方法及应用
WO2025219601A1 (en) * 2024-04-18 2025-10-23 4Moving Biotech New glp-1 receptor agonists for the treatment of joint diseases
CN118845994B (zh) * 2024-06-21 2025-06-03 超越健康科技(浙江)有限公司 一种用于骨关节退行性疾病的药物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005034961A1 (en) * 2003-10-01 2005-04-21 Optimer Pharmaceuticals, Inc. Treatment of a condition in a mammal with adminisration of aminosugar and uses thereof
EP2494983B1 (en) * 2004-11-12 2019-04-24 Novo Nordisk A/S Stable formulations of glp-1
WO2008023063A2 (en) * 2006-08-25 2008-02-28 Ares Trading S.A. Treatment of cartilage disorders with fgf-18
CN102271705A (zh) * 2008-12-22 2011-12-07 墨尔本大学 骨关节炎治疗
CN101987868B (zh) * 2009-07-30 2013-09-04 江苏豪森医药集团有限公司 Glp-1类似物的衍生物或其可药用盐和用途
US8716204B2 (en) * 2010-07-27 2014-05-06 Zimmer, Inc. Synthetic synovial fluid compositions and methods for making the same
FR2994848B1 (fr) * 2012-08-30 2014-08-22 Univ Paris Curie Traitement de l'arthrose par les hormones incretines ou leurs analogues
US20150150983A1 (en) * 2013-12-02 2015-06-04 Depuy Mitek, Llc Intra-articular Formulations and Methods for Treatment of Osteoarthritis
US10946074B2 (en) 2016-03-03 2021-03-16 Novo Nordisk A/S GLP-1 derivatives and uses thereof

Also Published As

Publication number Publication date
JP2025118608A (ja) 2025-08-13
EP4501362A2 (en) 2025-02-05
AU2019383576B2 (en) 2025-06-19
WO2020104833A1 (en) 2020-05-28
AU2025223913A1 (en) 2025-09-18
EP4501362A3 (en) 2025-02-19
BR112021009232A2 (pt) 2021-08-10
CN113038966A (zh) 2021-06-25
JP7661222B2 (ja) 2025-04-14
US20250144181A1 (en) 2025-05-08
EP3883594A1 (en) 2021-09-29
KR20210093252A (ko) 2021-07-27
CA3119940A1 (en) 2020-05-28
WO2020104917A1 (en) 2020-05-28
EP3883594C0 (en) 2025-07-09
JP2022507614A (ja) 2022-01-18
US20260069661A1 (en) 2026-03-12
AU2019383576A1 (en) 2021-06-03
ES3042788T3 (en) 2025-11-24
EP3883594B1 (en) 2025-07-09
HRP20251230T1 (hr) 2025-12-05
US20210401944A1 (en) 2021-12-30

Similar Documents

Publication Publication Date Title
PL3883594T3 (pl) Skład i metody regulacji proliferacji chondrocytów oraz zwiększania produkcji macierzy chrzęstnej
MA53019A (fr) Nouvelle composition de nutrition et de fortification de culture
IL261213B (en) A method implemented by the 'Blockchain' to control and distribute digital content
EP3813702A4 (en) BONE SCREW AND METHOD FOR MANUFACTURING THEREOF
SG11202103824YA (en) High quality cultured meat, compositions and methods for producing same
AU2018276117A1 (en) Animal feed supplement
EP3268035A4 (en) Compositions and methods for activating "stimulator of interferon gene" -dependent signalling
PL3211969T3 (pl) Źródło światła LED i sposób do regulacji tonacji barwy lub temperatury barwowej źródła światła LED
EP3263648A4 (en) Curable granular silicone composition and method for preparing same
EP3247359A4 (en) Composition and method for treating seizure disorders
EP3253228A4 (en) Animal feed composition and method of making same
IL276148A (en) A preparation and method for reducing platelet count through the administration of palinabolin
PL3353252T3 (pl) Sieciowalna kompozycja silikonowa do wytwarzania powłok antyadhezyjnych dla elastycznych podłoży i dodatek promotora przyczepności zawarty w tej kompozycji
SG11202103745WA (en) Method for activation/proliferation of t cells
HUE058905T2 (hu) Mesterséges porc és eljárás az elõállítására
EP3645144A4 (en) COMPOSITION AND METHOD OF REMOVAL OF HYDROGEN SULFUR AND MERCAPTANES
EP3735419A4 (en) PROCESS FOR INCREASING THE PROLIFERATION OF PANCREATIC BETA CELLS, PROCESS OF TREATMENT AND COMPOSITION
IL290068B1 (en) A system and method for sowing and growing a culture
IL289915A (en) Composition and method for adoptive immunotherapy
GB2568562B (en) Moldable compositions and methods of using thereof
GB2581882B (en) WNT compositions and methods of process from serum-free culturing conditions
EP3672599A4 (en) METHODS OF TREATING DEVELOPMENTAL AND / OR EPILEPTIC DISORDERS WITH ETIFOXIN
GB201707034D0 (en) Modified microorganisms and methods for production of useful products
GB201704835D0 (en) Compartmentalised gel matrix and method of production
SG11202000174UA (en) Process for one-pot liquefaction of biomass or coal and biomass